Home HOME Neoplasma 2021 Neoplasma Vol.68, No.1, p.180–189, 2021

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.68, No.1, p.180–189, 2021

Title: The impact of 18F-FDG PET/CT in the clinical management of patients with lymph node metastasis of unknown primary origin
Author: Petya Nikolaeva Nikolova, Valeria Hristova Hadzhiyska, Kiril Blagoev Mladenov, Mihaela Georgieva Ilcheva, Stefani Veneva, Violeta Vasileva Grudeva, Svetla Emilova Dineva, Yavor Nikolov Asenov

Abstract: The aim of this study was to evaluate the diagnostic performance and the utility of F-18-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET/CT) in the clinical management of patients presenting with lymph node metastasis of undefined primary origin (CUP). A total of 53 patients (34 males, 19 females) with a diagnosis of lymph node metastasis according to the histopathology and/or conventional imaging were enrolled in this retrospective study. Patients were divided into four groups according to the initial location of their metastasis - group 1, cervical lymph nodes (n = 39), group 2, axillary lymph nodes (n = 6), group 3, mediastinal lymph nodes (n = 2) and group 4, abdominal and pelvic lymph nodes (n = 6). The site of a probable primary malignancy suggested by PET/CT was confirmed by biopsy/further investigations or follow-up.
18F-FDG PET/CT accurately detected the primary carcinoma in 19 of 53 patients (36%), with head and neck cancer and lung carcinoma being the most common primary locations. The PET-CT scan results were negative for primary site localization in 13% of patients (false-negative), while 45% had true negative results, and 6% displayed false-positive results. Additional distant metastatic foci were identified in 21 of all patients (40%). The overall sensitivity, specificity, and accuracy rates of the study were identified as 73%, 89%, and 81%, respectively; in the group with cervical lymph node metastasis sensitivity 70% and specificity 84%.
To conclude, 18F-FDG PET/CT is a sensitive and selective procedure for detecting unknown primary tumors, especially in the clinical setting of cervical lymph node metastasis and its use should be encouraged earlier in pre-treatment phase of CUP-patients, leading to higher detection of probable primary sites, guiding subsequent biopsy, and more accurate detection of distant metastases in a single examination.

Keywords: cancer of unknown primary; 18F-FDG PET/CT; lymph node metastasis
Published online: 03-Sep-2020
Year: 2021, Volume: 68, Issue: 1 Page From: 180, Page To: 189
doi:10.4149/neo_2020_200315N263
Price: 24.00 €






© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.